These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18251668)

  • 1. Therapeutic options for human brucellosis.
    Al-Tawfiq JA
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):109-20. PubMed ID: 18251668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of human brucellosis.
    Solera J
    J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
    Hasanjani Roushan MR; Mohraz M; Hajiahmadi M; Ramzani A; Valayati AA
    Clin Infect Dis; 2006 Apr; 42(8):1075-80. PubMed ID: 16575723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to the antibiotic treatment of brucellosis.
    Pappas G; Solera J; Akritidis N; Tsianos E
    Int J Antimicrob Agents; 2005 Aug; 26(2):101-5. PubMed ID: 16039098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on brucellosis: therapeutic challenges.
    Solera J
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S18-20. PubMed ID: 20692127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.
    Roushan MR; Amiri MJ; Janmohammadi N; Hadad MS; Javanian M; Baiani M; Bijani A
    J Antimicrob Chemother; 2010 May; 65(5):1028-35. PubMed ID: 20215128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brucellosis: clinical presentation, diagnosis, complications and therapeutic options].
    Sakran W; Chazan B; Koren A
    Harefuah; 2006 Nov; 145(11):836-40, 860. PubMed ID: 17183958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different combination therapies in the treatment of human brucellosis.
    Ersoy Y; Sonmez E; Tevfik MR; But AD
    Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen.
    Pappas G; Seitaridis S; Akritidis N; Tsianos E
    Int J Antimicrob Agents; 2004 Nov; 24(5):502-7. PubMed ID: 15519485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter therapeutic study of 1100 children with brucellosis.
    Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
    Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline-rifampicin: physicians' inferior choice in brucellosis or how convenience reigns over science.
    Pappas G; Siozopoulou V; Akritidis N; Falagas ME
    J Infect; 2007 May; 54(5):459-62. PubMed ID: 17070921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
    Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
    Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infection of a total knee prosthesis with Brucella spp].
    Marbach F; Saiah L; Fischer JF; Huismans J; Cometta A
    Rev Med Suisse; 2007 Apr; 3(107):1007-9. PubMed ID: 17526375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence and relapse in brucellosis and need for improved treatment.
    Franco MP; Mulder M; Smits HL
    Trans R Soc Trop Med Hyg; 2007 Sep; 101(9):854-5. PubMed ID: 17604065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic strategy in spinal brucellosis.
    Alp E; Doganay M
    Int J Infect Dis; 2008 Nov; 12(6):573-7. PubMed ID: 18539496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
    Bayindir Y; Sonmez E; Aladag A; Buyukberber N
    J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.